We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LMND:NYSELemonade, Inc. analysis

Data as of Aug 25, 2026 - not real-time

Latest price
$53.86
Risk: high
9/10High risk

Summary

Lemonade, Inc. trades at $53.86, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 23.2% over the past 30 days. Relative strength is 47.5 — neutral — and the MACD signal is bullish. Price has been bracketed by support at $46.16 and resistance at $55.05.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 10.0% above where the shares trade now. Revenue is growing at 79.4% on a -14.2% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 95.6%, a beta of 2.81 and a maximum drawdown of 50.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 3 out of 10.

Top market events

  • Lemonade NYSE: LMND today announced that Tim Bixby, Chief Financial Officer, is scheduled to present at the Oppenheimer...
  • 27dLemonade: Favorable Reinsurance Shift And Pushing Toward ProfitsLemonade, Inc.
  • Detailed price information for Lemonade Inc LMND-N from The Globe and Mail including charting and trades.

Market outlook

Short term

< 1 year

Cautious

Model confidence4/104 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 65.23
  • MACD momentum is positive

Medium term

1–3 years

Cautious

Model confidence4/104 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 65.23
  • Analyst targets imply +10.0% versus the current price

Long term

> 3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Negative profit margin of -14.2%
  • Analyst targets imply +10.0% versus the current price
  • Negative return on equity of -27.0%

Key metrics

Financial health

Revenue Growth79.40%
Profit Margin-14.19%
P/E Ratio-61.9
ROE-26.96%
ROA-3.27%
Debt/Equity45.33
P/B Ratio8.3
Op. Cash Flow$21.2M
Free Cash Flow$94.4M
Industry P/E17.1

Technical analysis

TrendBearish
RSI47.5
Support$46.16
Resistance$55.05
MA 20$51.71
MA 50$59.57
MA 200$65.23
MACDBullish
VolumeDecreasing
Fear & Greed Index93.82

Valuation

Fair Value$44.22
Target Price$59.22
Upside/Downside9.96%
GradeOvervalued
TypeGrowth

Risk assessment

Beta2.81
Volatility95.60%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.